I agree that this site is using cookies. You can find further informations here.
X
Borgstrom, F.
201  results:
Search for persons X
?
1

POSB139 Predicting Quality of Life through Changes in Menst..:

Lilja, M ; Frisell, O ; Borgström, F..
Value in Health.  25 (2022)  1 - p. S88 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Is it time to consider population screening for fracture ri..:

Chotiyarnwong, P. ; McCloskey, E. V. ; Harvey, N. C....
Archives of Osteoporosis.  17 (2022)  1 - p. , 2022
Link: https://doi.org/10.1007/..
 
?
3

A micro-costing analysis of post-fracture care pathways: re..:

Talevski, J. ; Sanders, K. M. ; Lal, A....
Osteoporosis International.  33 (2022)  9 - p. 1895-1907 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Population screening for fracture risk in postmenopausal wo..:

McCloskey, E. V. ; Chotiyarnwong, P. ; Harvey, N. C....
Osteoporosis International.  33 (2022)  8 - p. 1631-1637 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Sex differences in recovery of quality of life 12 months po..:

Talevski, J. ; Sanders, K.M. ; Watts, J.J....
Osteoporosis International.  33 (2021)  1 - p. 67-75 , 2021
Link: https://doi.org/10.1007/..
 
?
6

P054 Clinical outcomes in people with cystic fibrosis treat..:

Lindblad, A. ; de Monestrol, I. ; Gilljam, M....
Journal of Cystic Fibrosis.  20 (2021)  - p. S54-S55 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Cost-effectiveness of romosozumab for the treatment of post..:

Söreskog, E. ; Lindberg, I. ; Kanis, J.A....
Osteoporosis International.  32 (2021)  3 - p. 585-594 , 2021
Link: https://doi.org/10.1007/..
 
?
8

A novel economic framework to assess the cost-effectiveness..:

Söreskog, E. ; Borgström, F. ; Lindberg, I....
Osteoporosis International.  32 (2021)  7 - p. 1301-1311 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Short time horizons for fracture prediction tools: time for..:

McCloskey, E. V. ; Borgstrom, F. ; Cooper, C....
Osteoporosis International.  32 (2021)  6 - p. 1019-1025 , 2021
Link: https://doi.org/10.1007/..
 
?
10

Long-term cost-effectiveness of screening for fracture risk..:

SCOOP study team ; Söreskog, E. ; Borgström, F....
Osteoporosis International.  31 (2020)  8 - p. 1499-1506 , 2020
Link: https://doi.org/10.1007/..
 
?
11

PMS67 EXPERIENCE AND PREFERENCE-BASED EQ-5D-3L VALUE SET DE..:

Svedbom, A. ; Borgstrom, F. ; Hernlund, E....
Value in Health.  22 (2019)  - p. S705-S706 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Correspondence in response to OSIN-D-18-00831 quantifying i..:

Kanis, J.A. ; Johansson, H. ; Harvey, N.C....
Osteoporosis International.  30 (2019)  2 - p. 525-526 , 2019
Link: https://doi.org/10.1007/..
 
?
13

Cost-Effectiveness of Abaloparatide for the Treatment of Po..:

Hansson-Hedblom, A ; Geale, K ; Borgstrom, F...
Value in Health.  21 (2018)  - p. S197 , 2018
Link: https://doi.org/10.1016/..
 
?
14

Characteristics of recurrent fractures:

Kanis, J. A. ; Johansson, H. ; Odén, A....
Osteoporosis International.  29 (2018)  8 - p. 1747-1757 , 2018
Link: https://doi.org/10.1007/..
 
?
15

PMS43 - AN ECONOMIC VALUE FRAMEWORK TO ASSESS THE COST EFFE..:

Jonsson, E. ; Borgström, F. ; Ström, O....
Value in Health.  21 (2018)  - p. S295 , 2018
Link: https://doi.org/10.1016/..
 
1-15